Business · 21/09/2017Updated: 10/17/2026 · 1 min read
FDA Withdraws Approval of 27 Abbreviated New Drug Applications
Summary
The Food and Drug Administration (FDA) has withdrawn the approval of 27 abbreviated new drug applications (ANDAs) from multiple applicants, following written notifications from the applicants that the drug products are no longer commercially available.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →